Logo image of HOVR

NEW HORIZON AIRCRAFT LTD (HOVR) Stock Fundamental Analysis

NASDAQ:HOVR - Nasdaq - CA64550A1075 - Common Stock

0.84  -0.06 (-6.29%)

Premarket: 0.9503 +0.11 (+13.13%)

Fundamental Rating

1

HOVR gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 65 industry peers in the Aerospace & Defense industry. Both the profitability and financial health of HOVR have multiple concerns. HOVR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

HOVR had positive earnings in the past year.
HOVR had a negative operating cash flow in the past year.
HOVR Yearly Net Income VS EBIT VS OCF VS FCFHOVR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 0 2M -2M 4M 6M 8M

1.2 Ratios

The Return On Assets of HOVR (7.06%) is better than 81.25% of its industry peers.
With a decent Return On Equity value of 7.49%, HOVR is doing good in the industry, outperforming 60.94% of the companies in the same industry.
Industry RankSector Rank
ROA 7.06%
ROE 7.49%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HOVR Yearly ROA, ROE, ROICHOVR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 0 -10 -20 -30 -40

1.3 Margins

HOVR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HOVR Yearly Profit, Operating, Gross MarginsHOVR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023

2

2. Health

2.1 Basic Checks

HOVR has less shares outstanding than it did 1 year ago.
HOVR has a better debt/assets ratio than last year.
HOVR Yearly Shares OutstandingHOVR Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 5M 10M 15M
HOVR Yearly Total Debt VS Total AssetsHOVR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

HOVR has an Altman-Z score of 1.62. This is a bad value and indicates that HOVR is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of HOVR (1.62) is worse than 75.00% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that HOVR is not too dependend on debt financing.
HOVR has a better Debt to Equity ratio (0.00) than 95.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.62
ROIC/WACCN/A
WACCN/A
HOVR Yearly LT Debt VS Equity VS FCFHOVR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

HOVR has a Current Ratio of 0.12. This is a bad value and indicates that HOVR is not financially healthy enough and could expect problems in meeting its short term obligations.
HOVR has a worse Current ratio (0.12) than 98.44% of its industry peers.
HOVR has a Quick Ratio of 0.12. This is a bad value and indicates that HOVR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.12, HOVR is not doing good in the industry: 98.44% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.12
Quick Ratio 0.12
HOVR Yearly Current Assets VS Current LiabilitesHOVR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 200K 400K 600K 800K

0

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to decrease by -15.02% on average over the next years. This is quite bad
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2Y-52.94%
EPS Next 3Y-33.26%
EPS Next 5Y-15.02%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HOVR Yearly Revenue VS EstimatesHOVR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M
HOVR Yearly EPS VS EstimatesHOVR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2025 2026 2027 2028 2029 2030 0 0.2 -0.2 0.4 0.6

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 1.58, the valuation of HOVR can be described as very cheap.
HOVR's Price/Earnings ratio is rather cheap when compared to the industry. HOVR is cheaper than 100.00% of the companies in the same industry.
HOVR's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.29.
Industry RankSector Rank
PE 1.58
Fwd PE N/A
HOVR Price Earnings VS Forward Price EarningsHOVR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HOVR Per share dataHOVR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

HOVR's earnings are expected to decrease with -33.26% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-52.94%
EPS Next 3Y-33.26%

0

5. Dividend

5.1 Amount

No dividends for HOVR!.
Industry RankSector Rank
Dividend Yield N/A

NEW HORIZON AIRCRAFT LTD

NASDAQ:HOVR (1/21/2025, 8:05:54 PM)

Premarket: 0.9503 +0.11 (+13.13%)

0.84

-0.06 (-6.29%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners5.78%
Inst Owner Change14.64%
Ins Owners8.74%
Ins Owner Change-5.24%
Market Cap20.64M
Analysts82.86
Price Target2.04 (142.86%)
Short Float %5.21%
Short Ratio0.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 1.58
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.18
P/tB 0.18
EV/EBITDA N/A
EPS(TTM)0.53
EY63.1%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0
BVpS4.68
TBVpS4.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.06%
ROE 7.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.12
Quick Ratio 0.12
Altman-Z 1.62
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2Y-52.94%
EPS Next 3Y-33.26%
EPS Next 5Y-15.02%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-16563.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3Y-60.02%
EBIT Next 5Y24.73%
FCF growth 1Y-21149.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-21149.2%
OCF growth 3YN/A
OCF growth 5YN/A